Balanced news tone
News Sentiment
ANIK sentiment intelligence
Anika Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+1.6% over one week, +6.0% over four weeks, trend active, and near fair-value range.
Anika Therapeutics to issue Q2FY26 results on July 29
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Anika Therapeutics grants 3,360 RSUs to new employee as inducement under Nasdaq rules.
Anika Therapeutics has granted 3,360 restricted stock units (RSUs) to a new non-executive employee. This grant, made on June 1, 2026, serves as an inducement for employment under Nasdaq rules and will vest in equal installments over three years, dependent on continuous service. T
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 21:09
- Source
- Pluang
New Anika hire receives 3,360 stock units as job inducement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Stock Titan
Anika Therapeutics (ANIK) Hovers Near Support With Minimal Price Movement - Resistance Breakout Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- DonanımHaber
President of Anika Therapeutics Picks Up 51% More Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 May 2026 13:36
- Source
- Simply Wall St.
Anika Therapeutics (ANIK) Q4 Profit Challenges Ongoing Unprofitability Narrative Ahead Of Q1 Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- simplywall.st
Bullish On Anika Therapeutics’s Pullback As Integrity Scales (NASDAQ:ANIK)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Seeking Alpha
Anika Therapeutics Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 14:20
- Source
- MarketBeat
Anika: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 11:14
- Source
- Associated Press
Anika Reports First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 11:05
- Source
- GlobeNewswire
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- Market source
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Apr 2026 07:00
- Source
- GlobeNewswire
New Anika employee gets 3,138 stock units vesting over 3 years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2026 07:00
- Source
- Stock Titan
ANIKA THERAPEUTICS ($ANIK) Releases Q4 2025 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Feb 2026 08:00
- Source
- Quiver Quantitative
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C.
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 26 Jan 2026 08:00
- Source
- GlobeNewswire
Osteoarthritis Therapeutics Market Size, Share | Growth [2034]
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jan 2026 09:41
- Source
- Fortune Business Insights
Anika Therapeutics (ANIK) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 00:25
- Source
- Stock Titan